Since the discovery of the first trypsinogen mutation in families with hereditary pancreatitis, pancreatic genetics has made rapid progress. The identification of mutations in genes involved in the digestive protease-antiprotease pathway has lent additional support to the notion that pancreatitis is a disease of autodigestion. Clinical and experimental observations have provided compelling evidence that premature intrapancreatic activation of digestive proteases is critical in pancreatitis onset. However, disease course and severity are mostly governed by inflammatory cells that drive local and systemic immune responses. In this article, we review the genetics, cell biology, and immunology of pancreatitis with a focus on protease activation pathways and other early events.
Keywords: Trypsinogen; Pancreatitis; Genetics; Inflammation; Cell Death. P ancreatitis is the leading cause for gastrointestinal disease-related hospital admissions and it is associated with considerable morbidity, mortality, and socioeconomic burden. 1 Recent years have shed light on the pathophysiology of pancreatitis, opening up new avenues for causal treatment. In this review article, we dissect the complexity of premature protease activation and its effect on local and systemic inflammation in pancreatitis.
Genetics of Pancreatitis
Acute pancreatitis (AP), recurrent AP (RAP), and chronic pancreatitis (CP) form a disease continuum. 2 The progression of a sentinel attack of AP to RAP and eventually to CP is often driven by chronic alcohol consumption or genetic risk factors. Genetic risk for RAP and CP overlaps, whereas genetic studies in AP are difficult to interpret in the absence of adequate follow-up that can exclude RAP and CP cases.
Most pancreatitis risk genes code for digestive proteases, a trypsin inhibitor, or other proteins highly expressed in the pancreas. Functional studies have classified the various mutations and other genetic alterations into pathologic pathways driving pancreatitis onset and progression. We discuss the trypsin-dependent, mis-folding-dependent, and ductal pathways of pancreatitis risk.
Trypsin-Dependent Pathway of Genetic Risk in CP
Pancreatic acinar cells secrete digestive proteases in inactive precursor forms that are flushed from the ductal system in a sodium bicarbonate-rich fluid. Trypsinogen, the precursor to trypsin, becomes activated by the serine protease enteropeptidase in the duodenum. 3 Trypsin activates chymotrypsinogens, proelastases, and procarboxypeptidase B1 (CPB1), whereas activation of procarboxypeptidases A1 (CPA1) and A2 (CPA2) requires the concerted action of trypsin and chymotrypsin C (CTRC). 4 Trypsinogen also can be activated by trypsin, and this process is called autoactivation. 3 Premature, intrapancreatic activation of trypsinogen can occur by autoactivation or can be catalyzed by the lysosomal cysteine protease cathepsin B. Protective mechanisms that prevent trypsinogen activation in the pancreas include trypsin inhibition by the serine protease inhibitor Kazal type 1 (SPINK1) and trypsinogen degradation by CTRC and cathepsin L. [5] [6] [7] Although the principal action of CTRC is to promote trypsinogen degradation, it also enhances trypsinogen activation by processing the trypsinogen activation peptide to a shorter form, which is more sensitive to trypsin-mediated activation [7] [8] [9] ( Figure 1 ). As discussed below, certain trypsinogen mutations can hijack this mechanism and thereby stimulate trypsinogen activation to a pathologic extent. Human genetic studies strongly support trypsinogen autoactivation and CTRC-dependent trypsinogen degradation as key mechanisms determining intrapancreatic trypsin activity, whereas similarly compelling genetic evidence for the role of cathepsins B and L has been lacking. 10 
Cationic Trypsinogen Mutations
Mutations in human cationic trypsinogen (PRSS1) cause autosomal dominant hereditary pancreatitis (HP) with incomplete penetrance or act as risk factors in sporadic CP. 7, 11 Approximately 90% of PRSS1-mutation-positive HP families carry the p.N29I, p.R122C, or p.R122H mutation in the heterozygous state. Mechanistically, the p.R122C and p.R122H mutations prevent CTRC-mediated trypsinogen degradation. 9 The p.N29I mutation has multiple distinct effects on trypsinogen biochemistry, the combination of which markedly increases trypsinogen autoactivation. These effects include an increase in N-terminal processing, decreased CTRC-dependent degradation, and a slightly increased propensity for autoactivation. 9 The p.A16V variant sensitizes the activation peptide of trypsinogen to CTRC-mediated processing, which in turn enhances autoactivation. 8, 9 Pathologic trypsin levels generated by mutation p.A16V are lower than those seen with the p.R122H variant, which explains the decreased penetrance of the p.A16V variant. More recently, mutation p.P17T was found to exhibit characteristics that were similar to those of p.A16V. 12 Rare mutations affecting the activation peptide of cationic trypsinogen (p.D19A, p.D21A, p.D22G, p.K23R, and p.K23_I24insIDK) robustly stimulate autoactivation independently of CTRC. [13] [14] [15] Cell culture experiments have indicated that these activation peptide mutants are secreted poorly because of intracellular activation and degradation, which can lead to cellular stress and consequent acinar cell death. 16 Taken together, PRSS1 mutations stimulate activation of cationic trypsinogen by decreasing CTRC-dependent trypsinogen degradation, increasing CTRC-mediated processing of the activation peptide, or directly stimulating autoactivation. Genomewide association studies (GWASs) have identified a commonly occurring haplotype in the PRSS1 and anionic trypsinogen (PRSS2) locus that slightly decreases CP risk (odds ratio [OR] 1.5), with a more pronounced effect in alcoholic CP. [17] [18] [19] A variant (c.À204C>A) that lies in the promoter region of PRSS1 and decreases trypsinogen expression appears to be responsible for this small protective effect.
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SPINK1 Mutations
The association between the most common p.N34S SPINK1 variant and CP was first described by a candidate gene study in 2000. 21 A meta-analysis reported a carrier frequency of 9.7% in patients with CP and 1% in controls with an average OR of 11, making the p.N34S the clinically most significant risk factor for CP. 22 When considering European populations only, p.N34S increased CP risk by approximately 10-fold. 23 Although several studies have attempted to identify the functional effect of p.N34S and its associated haplotype, the molecular mechanism underlying CP risk remains unclear. Neither p.N34S nor any of the 4 linked intronic variants affect trypsin inhibitory function or cellular expression of SPINK1. [24] [25] [26] [27] Interestingly, in pancreatic cancer cell lines carrying the heterozygous p.N34S variant, decreased expression of the mutant allele was observed compared with the wild-type allele. 28 The investigators suggested that the c.À4141G>T variant or a hitherto unknown variant located in the 5 0 region of the gene might be responsible for the decreased expression of the p.N34S allele. The second most frequently reported SPINK1 haplotype in CP contains the c.À215G>A promoter variant and the c.194þ2T>C variant in intron 3. 21, 29 This haplotype was observed more frequently in East Asia than in Europe. 7 Functional studies have shown that the c.194þ2T>C variant causes skipping of exon 3, which results in diminished SPINK1 expression. 27, 30, 31 However, the c.À215G>A variant increases promoter activity, which might mitigate the effect of the c.194þ2T>C mutation and allow for some residual SPINK1 expression even in homozygous carriers. 32, 33 A large number of rare or private alterations in SPINK1 have been found in CP, which cause loss of SPINK1 function by various mechanisms. 7 Protective PRSS2 Variant Although PRSS1 and PRSS2 share 90% identity at the amino acid level and PRSS2 rapidly auto-activates, no pathogenic PRSS2 variants have been identified in HP or sporadic CP. 34, 35 The absence of PRSS2 mutations in CP could be due to the more effective CTRC-mediated degradation of anionic trypsinogen, which would prevent intrapancreatic activation of the enzyme even if it were mutated. 36 However, a protective variant p.G191R with a w3-to 6-fold effect and approximately 5% population frequency was discovered. 35, 37 The mutation introduces a new trypsin cleavage site into anionic trypsinogen, which increases autocatalytic proteolysis and inactivation. 35 
CTRC Mutations
Direct DNA sequencing of the CTRC gene in patients with nonalcoholic CP showed heterozygous mutations in 4% of patients that increased CP risk by 5-fold on average. 38, 39 The mutations cause loss of CTRC function by various mechanisms, which include defective secretion from mis-folding, resistance to trypsin-mediated activation, catalytic deficiency, or increased degradation by trypsin. 40, 41 Considering the clinically significant variants, p.A73T exhibits a severe secretion defect, p.K247_R254del is inactive and prone to degradation, p.R254W is degraded by trypsin, and p.V235I has partly decreased activity. 40 Subsequent studies reported a frequent p.G60¼ variant found in approximately 30% of patients with CP. [42] [43] [44] [45] The heterozygous p.G60¼ increases the risk of CP by 2.5-fold, whereas the homozygous state increases the risk by 10-fold. 43, 45 The variant is associated with decreased CTRC mRNA expression (GTEx Portal), possibly because of altered pre-mRNA splicing.
CTRB1-CTRB2 Locus Inversion
A recent European GWAS identified a large inversion at the CTRB1-CTRB2 locus that modestly (OR 1.35) modifies the risk for alcoholic and nonalcoholic CP. 19 The inversion changes the expression ratio of the CTRB1 and CTRB2 chymotrypsin isoforms in such a manner that protective trypsinogen degradation is increased and CP risk is decreased. In China, the reported population frequency of the inverted (major) allele is 99.6%; thus, the allele is virtually fixed and does not contribute to CP risk. 46 A mouse model with genetic deletion of the major mouse chymotrypsin CTRB1 exhibited increased intra-acinar trypsin activation and more severe pancreatitis induced by the secretagogue cerulein. 47 These observations provided the first in vivo proof for the protective role of chymotrypsin-mediated trypsinogen degradation against pancreatitis.
Mis-folding-Dependent Pathway of Genetic Risk in CP
More recently, an alternative pathomechanism seemingly unrelated to premature intrapancreatic trypsinogen activation has been identified, in which mutation-induced mis-folding and consequent endoplasmic reticulum (ER) stress lead to acinar cell damage and pancreatitis. 48 
Mis-folding-Associated PRSS1 Mutations
In 2009, a subset of PRSS1 variants was found to cause decreased secretion, intracellular retention, and increased ER stress markers, as judged by in vitro cell culture experiments. 49 These PRSS1 mutations occur rarely and are mostly associated with sporadic disease (eg, p.C139F, p.C139S, p.G208A), but also have been found in HP families with incomplete penetrance (p.L104P, p.R116C). 48 Variant p.G208A is prevalent in East Asia (4% of CP cases) and was detected in Europe only in a single case thus far.
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Mis-folding-Associated CPA1 Mutations A candidate gene study in 2013 reported that mutations in the CPA1 gene are associated with CP (OR w25), especially with early-onset disease (OR w80). 52 The vast majority of pathogenic CPA1 variants occur with low frequency and are mostly found in sporadic CP. The p.S282P variant was described in 2 HP families. 53 Pathogenic CPA1 variants cause proenzyme mis-folding, resulting in a secretion defect, intracellular retention, and ER stress. 52, 53 In contrast to CPA1, variants of CPB1 and CPA2 are not associated with CP. 54 Interestingly, ER stress-inducing CPA1 and CPB1 variants were over-represented in patients with pancreatic cancer without a clinical history of RAP or CP. 55 Most of these variants caused premature truncation and did not overlap with those found in CP. A mouse model for the misfolding-dependent pathway was described recently. This study showed that CPA1 N256K knock-in mice harboring the most frequent p.N256K human CPA1 mutation develop spontaneous and progressive CP and exhibit signs of ER stress in their pancreas. 56 Mis-folding-Associated CEL Mutations and CEL-HYB Allele
Single-nucleotide deletions in the last exon of the CEL gene encoding carboxyl ester lipase cause maturity-onset diabetes of the young type 8 (MODY8). 57 The deletions alter the reading frame of the C-terminal variable number tandem repeat sequence, resulting in CEL proteins with unnatural extensions that are prone to aggregation. 58, 59 The exocrine dysfunction in MODY8 is in all likelihood caused by mis-folding-induced ER stress and consequent acinar cell loss. A hybrid CEL allele (CEL-HYB1) formed between CEL and its neighboring pseudogene CELP was over-represented in idiopathic CP by approximately 5-fold vs the average population frequency of 0.5%-1%. 60 In cell culture experiments, the hybrid protein was secreted poorly because of intracellular retention, suggesting that the CEL-HYB1 variant can increase CP risk by the mis-folding-dependent pathway. A second hybrid CEL allele (CEL-HYB2) that does not associate with CP was described in Asian populations. 61 Interestingly, the CEL protein carries blood group antigens and a GWAS in 2015 indicated that fucosyl-transferase 2 nonsecretor status and blood group B are risk factors for CP. 62 Although other studies in ethnically mixed cohorts failed to replicate this association, 63, 64 with the exception of azathioprine-induced pancreatitis in patients with inflammatory bowel disease, 65 it is still interesting to speculate that the observed effects might have been due to changes in CEL folding or trafficking.
Ductal Pathway of Genetic Risk in CP
CFTR Variants
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cyclic adenosine monophosphateregulated chloride-bicarbonate channel localized to the apical plasma membrane of epithelial cells 66 ( Figure 2 ). CFTR mutations disrupt channel activity or affect membrane levels and are associated with various phenotypes, ranging from asymptomatic state to multiorgan symptoms leading to the diagnosis of cystic fibrosis in homozygous carriers of severe mutations. Observations that heterozygous and compound heterozygous CFTR mutations are associated with CP were reported by 2 studies in 1998. 67, 68 In the first analysis of the entire CFTR coding region, the frequency of abnormal CFTR alleles in patients with CP was 18.6% compared with 9.2% in controls. 69 More recent large cohort analyses have corroborated the pathogenic role of CFTR variants in CP, although the effect and frequency of CFTR variants was less pronounced than reported previously. 39, 70, 71 Heterozygous carrier status of the severe p.F508del mutation confers a small risk for CP (OR 2.5), whereas the mild p.R117H mutation increases risk by approximately 4-fold. Compound heterozygous state for 1 severe and 1 mild CFTR allele represents strong risk for CP and can be considered causative. 70 The role of common polymorphic CFTR alleles (eg, T5, TG12) and the non-cystic fibrosis-causing, so-called bicarbonate-defective CFTR variants in CP remains controversial because the preponderance of data does not support their association with CP. 66 Unlike CFTR, variants in the solute-linked carrier 26 member 6 anion transporter (SLC26A6) do not alter the genetic risk in CP.
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CLDN2 Variants
GWASs of CP identified several single-nucleotide peptides in the claudin 2 (CLDN2) and MORC4 locus to be associated with CP risk. 17, 19 The OR was approximately 2 and the effect was more pronounced in alcoholic CP. Within this locus, CLDN2 seems to be the clinically relevant risk gene, because it is expressed in pancreatic ducts at low levels as a tight junction protein. It was proposed that CLDN2-MORC4 variants might cause CLDN2 mis-localization. Additional work is required to clarify the mechanism of action of this risk locus and to confirm whether assignment to the ductal pathway is appropriate ( Figure 2 ).
CASR Variants
The calcium-sensing receptor (CASR) regulates calcium homeostasis through parathyroid hormone secretion and renal tubular calcium reabsorption. Functional CASR also is expressed in the pancreas, including ductal cells where CASR can respond to high calcium concentrations in the juice by increasing ductal fluid secretion, thereby preventing stone formation and pancreatitis 73 ( Figure 2 ). A US population-based study failed to demonstrate the previously anticipated association between CASR variants and the SPINK1 p.N34S haplotype, but reported the p.R990G variant increased CP risk, especially in subjects with moderate or heavy alcohol consumption. 74 More recently, a French study found over-representation of rare CASR coding variants in idiopathic CP and a significant association of the p.A986S variant, but only in the homozygous state, with CP. 75 However, the previously reported association with the p.R990G variant was not observed in this cohort. Taken together, current evidence does not support a clear role for CASR variants in CP pathogenesis.
In summary, human genetic data indicate that premature activation or mis-folding of pancreatic proteases play a central role in the onset of pancreatitis and progression to CP (Supplementary Table 1 ).
Role of Proteases in Pathophysiology and Cell Biology of Pancreatitis
Although genetic evidence for the involvement of the protease-antiprotease balance in the pathogenesis of pancreatitis dates back only 2 decades and focuses mainly on CP, pathophysiologic and biochemical investigations have implicated this system for more a century. Because of the lack of adequate animal models and the inability to keep isolated pancreatic acinar cells in culture for long periods, experimental studies have focused primarily on AP. The relative importance of the pathways discussed below might change with respect to etiology. It is our general understanding that these mechanisms also are relevant to CP, although experimental evidence is mostly lacking.
Autodigestion by Pancreatic Proteases
The pathophysiologic concept of autodigestion was first developed by the Austrian pathologist Hans Chiari in Prague more than 120 years ago. He claimed that pancreatitis was caused and driven by the glands' digestive properties. 76 Since then, the pathomechanism of premature activation of pancreatic enzymes and its contribution to disease severity and progression have captured the attention of many pancreatologists. Bialek et al 77 first reported that protease activation during pancreatitis begins in the exocrine pancreas and Hofbauer et al 78 reported that it begins in a membrane-confined vesicular compartment and parallels acinar cell damage. Although the fact that activation of digestive proteases is an early event during AP is widely accepted, the question of where and through what mechanism this process is initiated and whether it plays a role in chronicity remain under debate.
Protease Activation During Pancreatitis-Clues From Mechanistic Studies
Role of Calcium for Intracellular Protease Activation. States of hypercalcemia, such as primary hyperparathyroidism, are a risk factor for the development of AP in humans and rats. [79] [80] [81] Intracellular calcium concentrations and compartmental distribution in acinar cells are tightly regulated because calcium serves as a second messenger for the physiologic release of digestive enzymes in response to vagal nerve stimulation or humoral activation. 82, 83 After intraperitoneal treatment of rats with supramaximal doses of cerulein, an analogue of cholecystokinin, 84 a timedependent disruption of the physiologic oscillating intracellular calcium signal was observed in rat acini using the Ca 2þ -sensitive dye fura-2. 85 When using for the first time fluorescent trypsin substrates that allow the subcellular imaging, localization, and quantification of protease activation, 86 Krüger et al 87 found that a specific extended plateau release of calcium at the apical pole of acinar cells is necessary for premature trypsin activation to occur, which is different from the calcium oscillations required for enzyme secretion. These findings were confirmed by others who also found that acetylcholine-or cholecystokinin (CCK)-induced intracellular protease activation was associated with the formation of cytoplasmic vacuoles in acinar cells that resemble those overserved in experimental pancreatitis in vivo 88 and that inhibition of calcium release also inhibits the formation of these vesicles. 89 Acinar cells can replace calcium for magnesium in its stores and, when this is done, not only the premature activation of proteases in vitro and in vivo but also the severity of pancreatitis is significantly decreased. 90 Two ongoing clinical trials (1 in AP and 1 in CP) are based on this observation. Orabi et al 91 took the concept of calcium-dependent protease activation further by showing that AP induced by supramaximal doses of the muscarinic agonist carbachol can be abrogated by inhibition of the intracellular calcium channel ryanodine receptor, which is located at the basolateral membrane of acinar cells. Therefore, the importance of spatial distribution of calcium to the apical pole might be a specific feature of the cerulein model. Interestingly, carbachol-induced protease activation is more severe if cells are pretreated with ethanol. Calcium signaling also could play a role in other forms of experimental pancreatitis, such as bile acid-induced pancreatitis, 92 pressure-induced pancreatitis, and pancreatitis after endoscopic retrograde cholangiopancreatography. 93 Experimental pancreatitis can be ameliorated by modulating calcium release from intracellular stores or influx through the plasma membrane by pharmacologic inhibition of inositol triphosphate receptor (predominantly types 2 and 3) signaling 94, 95 or calcium release-activated calcium modulator 1. 96, 97 The calcium-dependent protease activation also heavily depends on calcineurin, a calcium-activated phosphatase, and its downstream signaling through the transcription factor nuclear factor of activated T cells. Inhibition of calcineurin by inhibitors or in mice lacking calcineurin subunits causes decreased intracellular protease activity in secretagogue or bile acid-induced pancreatitis, without affecting vesicular transport.
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Mechanisms of Protease Activation. Three major concepts have been investigated over the past decades: autoactivation, spatial redistribution, and fusion of zymogen granules with other organelles and failure of protective mechanisms.
Autoactivation of Trypsin. There is strong evidence from human genetic studies indicating that autoactivation of trypsinogen 100 causes CP in affected humans. 9 In contrast, trypsinogen autoactivation is unimportant in experimental cerulein-induced pancreatitis. Inhibition of active trypsin by the reversible chemical inhibitor S124 could prevent trypsin activity in experimental cerulein-induced AP, but had no effect on the generation of the trypsin activation peptide (TAP) or active trypsin after washout of S124, thus indicating that hydrolysis of trypsinogen to trypsin appeared in a trypsinindependent fashion. 101 Activation by Lysosomal Proteases. Inhibition of the lysosomal hydrolase cathepsin B by the cysteine protease inhibitor E-64d leads to a significant decrease in trypsin activity and TAP formation, indicating that the trypsin activation in response to cerulein depends on cathepsin B. [101] [102] [103] Similarly, in cathepsin B knockout mice, trypsin activation is significantly inhibited after cerulein administration. 104 In the past, it was thought that cathepsin B 105 and trypsinogen under physiologic conditions are not located in the same cell organelles (zymogen granules for exocytosis vs lysosomes for degradation of content of endosomes and autophagosomes). In 1998, investigators showed in subcellular fractions of cerulein-treated acini a colocalization of cathepsin B and digestive enzymes, including trypsin and TAP, in heavy fractions 78 containing zymogen granules and lysosomes early in the disease course and later a shift of trypsin and cathepsin B activity to the cytosol. 106 This confirmed earlier findings from in vivo studies that indicated a fusion of zymogen-containing vacuoles with lysosomes in secretagogue-, duct obstruction-, or diet-induced AP. [107] [108] [109] [110] [111] [112] Intracellular activation of proteases other than trypsin, such as chymotrypsin and carboxypeptidase B, also depend on non-physiologic colocalization with other cell components, but are independent of cathepsin B.
113 Mis-sorting in the exocrine machinery, secretion blockage, and reuptake of previously secreted proteases by endocytosis have been described under experimental conditions. The fact that an acidic pH, as found in lysosomes, enhances secretagogue-dependent zymogen activation supports the fusion hypothesis. 114 A very recent study reported that CCK or ethanol treatment depletes acinar cells of syntaxin 2, a key regulator of apical exocytosis, thus leading to increased basolateral exocytosis and formation of autolysosomes mediated by syntaxins 3 and 4, in which trypsinogen activation takes place. 115 Inhibition of syntaxin-4-mediated basolateral exocytosis in experimental pancreatitis decreases disease severity. 116 Another concept introduces endocytic vacuoles (EVs) as the site of intracellular trypsinogen activation. These occur under physiologic and pathophysiologic conditions after compound exocytosis of zymogen granules. 117 EV formation is calcium dependent. 118 Their content is acidic and calcium rich and, after supramaximal CCK or taurocholate stimulation, trypsin activity within these post-exocytic structures can be visualized using fluorescent dyes. 119 During pancreatitis, EVs are larger than normal and tend to fuse with the plasma membrane or even rupture, discharging active trypsin into the cytosol or extracellular space. This instability is believed to be caused by disruption of otherwise protective actin filaments surrounding the EV. 120 However, rupture of EVs is independent of trypsin or cathepsin B activity. Secretory blockage can contribute to these events. In experimental pancreatitis, vesicle-associated membrane protein-8-mediated secretion is impaired because of a loss of early endosomal proteins, resulting in retention of trypsinogen and transformation to active trypsin in a cathepsin-dependent manner. Knockout of vesicle-associated membrane protein-8 protects against pancreatitis and restoration of early endosomal trafficking decreases severity of pancreatitis. 121, 122 Vesicular trafficking is regulated in a calciumdependent manner.
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Loss of Trypsin Inhibitors. Little is known about the role of failing protective mechanisms for protease activation in the early phase of pancreatitis. The most potent cellular trypsin inhibitor is SPINK1. Although SPINK1 mutations are among the most common genetic risk factors for the development of recurrent AP and CP, thus far, none of the described mutations seemed to impair SPINK function and therefore do not explain the increased risk for pancreatitis. [24] [25] [26] [27] In mice carrying a heterozygous SPINK3 deletion, a significant decrease of functional SPINK does not lead to the development of spontaneous pancreatitis or more severe disease after supramaximal cerulein administration compared with wild-type controls. 125 The fact that mice with a homozygous SPINK3 deletion develop pancreatic atrophy and that this phenotype can be rescued by transgenic expression of rat pancreatic secretory trypsin inhibitor 1 125 point toward a role of trypsin inhibitors during pancreatic development but do not explain that role in pancreatitis.
In conclusion, the current cumulative evidence suggests a cathepsin B-dependent mechanism of protease activation in experimental pancreatitis.
Cell Death Cause or Consequence of Protease Activation?
Premature intracellular protease activation in acinar cells leads to cell injury. Type of cell death, be it necrosis, apoptosis, autophagy, necroptosis, or pyroptosis, determines disease severity. 126 Necrosis is understood as an unregulated response to damage. In animal models of AP, approximately 1%-5% of acinar cells undergo apoptosis and severity of pancreatitis is inversely correlated to the rate of apoptosis. 127 Macroautophagy is a multistep, lysosomal-driven, adaptive process by which cells degrade cytoplasmic organelles and long-lived protein. 128 Pancreatitis presents with impaired autophagic flux evident by vacuole accumulation. 129 Currently, it is debated whether impaired autophagy stimulates cell death through accumulation of damaged mitochondria mediating an inflammatory response through a reactive oxygen species (ROS)-dependent mechanism as in lysosome-associated membrane protein 2 130 or Atg7-knockout animals 131 or whether autophagy prevents an inflammatory response as in Atg5-knockout mice. 132, 133 The regulated process of necrosis is termed necroptosis and is triggered by tumor necrosis factor (TNF), TNF-related apoptosis-inducing ligand, Fas ligand, interferon type 1, and Toll-like receptors (TLRs), which are released in the early phase of AP in response to protease activation. 134 Receptor-interacting protein 1 (RIP1) and RIP3 form a phosphorylated complex, the necrosome, and phosphorylate mixed-lineage kinase domain-like, resulting in membrane rupture. Forty percent of cells undergo necroptosis in pancreatitis and RIP3 deletion or treatment with necrostatin ameliorates pancreatitis. 135, 136 Necroptosis releases damageassociated molecular patterns (DAMPs) and those will activate the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) pathway, resulting in pyroptosis. 137 Pyroptosis is an innate immune sensing mechanism with poorly understood upstream signaling. Nevertheless, some interesting inhibitors are known, such as lactate, b-hydroxybutyrate, and aspartate. The term pyroptosis describes activation of the inflammasome through NLRP3. The inflammasome is a macroscopic cytosolic protein complex that proteolytically cleaves interleukin (IL) 1b and pro-IL18 and releases high mobility group box 1 protein. NLRP3 activation requires lysosomal rupture and cathepsin release, calcium influx, and mitochondria-derived ROS production and thus is closely linked to pancreatitis. 138, 139 However, NLRP3 expression is restricted to innate immune cells. 140 Cell death pathways in pancreatitis intersect. Caspase 3 activation can induce not only apoptosis but also pyroptosis. Necroptosis can shift to pyroptosis by caspase 8 activation and necroptosis activates pyroptosis. 141 Currently, we have not understood why some of our patients deteriorate and develop a necrotizing course of pancreatitis. A shift of regulated cell death from apoptosis to pyroptosis and stimulation of necroptosis might explain this observation. Inhibition of pyroptosis, for example, by using Ringer's lactate for volume resuscitation 142 or inhibition of necroptosis by necrostatin, 143 might well be a way forward in the treatment of pancreatitis.
An interesting question is whether cell death is a result of premature protease activation or a consequence of inflammation. The answer is ambiguous: Talukdar et al 106 reported a direct effect on lysosomal stability mediated by active trypsin and lysosomal rupture leading to the release of cathepsins into the cytosol, causing dose-dependently apoptosis or necrosis. Our group showed that inhibition of protease activation, especially trypsin by specific inhibitors, results in a decreased rate of apoptosis but does not affect necrosis. 144 Thus, cell death is a result of intracellular protease activation, but this has been shown only for isolated acinar cells mimicking the early phase of pancreatitis. Taking into account pyroptosis and necroptosis, inflammation is the origin and consequence of cell death in pancreatitis (Figure 3) .
Protease Activity and Disease Severity
This raises the question of whether intracellular protease activation of trypsin as it is linked to cell death also can mediate systemic disease severity. The notion that trypsin activation is linked to disease severity is supported by the correlation of TAP urine levels to severity in patients with AP. 145 However, several studies have questioned the role of trypsin for severity of pancreatitis. Expression of mutant human trypsin bearing the HP mutation R122H in mice leads to slightly more severe cerulein pancreatitis, 146 but, when compared with mice expressing normal human trypsinogen, there is no increase in disease severity. Moreover, the effect seems to be not solely dependent on trypsin, because mice with human trypsin mutations (R122H or N29I) show lower trypsin activity after cerulein hyperstimulation. This might be explained in part by a higher rate of acinar cell apoptosis even in untreated animals transgenic for human trypsinogen. 147 A similar effect is seen in PACEtryp(on) mice, which conditionally express an endogenously activated trypsinogen within pancreatic acinar cells. Those mice will develop AP in a trypsin activity-dependent way, which can lead to organ dysfunction and mortality, but they also show pronounced caspase 3 activation with consecutive apoptotic loss of acinar cells and replacement by fatty tissue. 148 Similarly, Archer et al 149 described a transgenic mouse, in which the human mutation R122H was inserted in the murine PRSS1 gene. Those mice developed spontaneous pancreatitis and showed a more pronounced inflammatory infiltrate and cellular damage in response to cerulein. The fact that the predominant way of cell death determines the overall severity of experimental pancreatitis in mice has been demonstrated in animals with deletion for cathepsin L. Cathepsin L degrades trypsinogen into an inactive elongated TAP, but cathepsin L deficiency leads to a milder form a of cerulein-induced pancreatitis, which is linked to a shift from necrosis to apoptosis. 6 The most convincing data questioning the role of trypsin for disease severity were generated using a mouse strain lacking trypsinogen 7, the murine counterpart of human cationic trypsinogen. Dawra et al 150 and Sah et al 151 found that a significant decrease in trypsin and chymotrypsin activity after cerulein hyperstimulation in these mice had no effect on disease severity for cell death or local or systemic inflammation in AP and CP models, which they claimed was mediated by a mechanism dependent on nuclear factor k light-chain enhancer of activated B cells (NFkB). This confirms previous findings generated in the PACE-tryp(on) model, in which NFkB -activation was independent of increased intracellular trypsin activity in vitro.
152 Figure 3 . Trypsinogen activation and cell death in pancreatic acinar cells. Intracellular trypsinogen activation is an early event at the onset of experimental AP. Supramaximal secretagogue-receptor stimulation or activation of bile salt receptors leads to an unphysiologic peak-plateau calcium signal. This results in disrupted exocytosis of zymogen granules, secretory blockage, zymogen retention, and formation of EVs, which contain trypsin and trypsinogen, taken up from the extracellular space. Those EVs colocalize and fuse with lysosomes containing cathepsin B, which in turn transforms trypsinogen into active trypsin. Owing to increasing instability, EVs often rupture, releasing trypsin and cathepsin B into the cytosol. Active trypsin is believed to induce mainly apoptosis, a silent form of cell death, which suppresses inflammation. In contrast, if the pathologic calcium release cannot be contained, then rapid energy depletion occurs and cells undergo necrosis, during which the plasma membrane becomes leaky and cellular components (eg, DNA or mitochondria) reach the extracellular space. Those will be recognized by leukocytes, which will be activated by the inflammasome signaling pathway. IL1b and TNFa release and pyroptosis occur. If TNFa reaches the basolateral membrane of previously unaffected or slightly damaged acinar cells, then it can induce another form of programmed cell death (ie, necroptosis). PLC, phospholipase C.
Role of Systemic Inflammation in Pancreatitis
NFkB Activation-Initial Step of Inflammation
The activation of NFkB is an early event during pancreatitis and occurs within the first minutes after onset of the disease. 153, 154 One main function of NFkB is transcriptional regulation of the immune response. 155 The principal pathway of NFkB signal transduction is depicted in Figure 4 . The fact that NFkB is already present in the cytoplasm explains its rapid activation after induction of pancreatitis. 153, 154 Intra-acinar protease activation and NFkB activation are early cellular events during pancreatitis, 153, 154 which have been suggested to occur independent of each other, 151 but follow a similar kinetic. Trypsinogen activation depends on intracellular Ca 2þ signaling 87 and NFkB activation also can be induced by protein kinase C and Ca 2þ , which could be the reason for parallel kinetics. 156 The deletion of trypsinogen 7 or cathepsin B, either of which results in greatly decreased protease activation, 104, 144, 151 does not influence NFkB activation during cerulein-induced pancreatitis. 151 This can be regarded as evidence that protease activation does not directly lead to NFkB activation in acinar cells, whereas NFkB activation can still interact with protease activity: the transcriptional regulation of serine protease inhibitor 2a is mediated by NFkB and can inhibit trypsin activity in a mouse model of acute pancreatitis (Figure 4) . 157 These results suggest a more complex role of NFkB during disease progression that is not restricted to proinflammation. 158 Surprisingly, the pancreas-specific deletion of Rel-A(p65) resulted in increased systemic inflammation and pancreatic necrosis. 159 In contrast, the pancreas-specific deletion of NFkB inhibitor a resulted in nuclear translocation of Rel-A and ameliorated pancreatitis. 157 The same phenotype was observed in mice deficient in myeloid differentiation primary response 88 (MyD88), which developed a more severe disease phenotype compared with controls. 160 MyD88 is a central adaptor for the TLR-IL1-receptor signaling pathway, which induces NFkB activation. These results ultimately suggest a protective role of NFkB activation in pancreatic acinar cells. Other studies attributed a more critical role for NFkB in disease severity. Mice that constitutively overexpress the active inhibitor of NFkB kinase subunit b (IKKb) under a pancreas-specific promoter showed chronic infiltration of immune cells associated with an increased disease severity after cerulein stimulation. 161, 162 However, the infiltration of immune cells alone, or the constitutive activity of NFkB in acinar cells, did not result in AP, organ damage, and necrotic or apoptotic cell death 162 ; an additional pathophysiologic stimulus was still needed. The increased severity of pancreatitis in IKKb-overexpressing mice can be They are induced by cytoplasmic Ca 2þ influx, but NFkB does not depend on trypsinogen activation. The phosphorylation of IkBa, followed by proteosomal degradation and nuclear translocation of NFkB (p65-p50) occurs in parallel to protease activation. NFkB as a transcription factor acts in 2 directions; first, transcriptions of proinflammatory genes, such as IL6 or TNFa, initiate the immune response; and second, the transcription of prosurvival genes. Therefore, NFkB can directly influence protease activity to protect cells by the up-regulation of serine protease inhibitor 2a. CTSB, cathepsin B; IkBa, inhibitor of NFkB alpha; IkBb, inhibitor of NFkB beta; NEMO, NFkappa-B essential modulator; PLC, phospholipase C; Ub, ubiquitin.
explained by the presence of leukocytes within the pancreas, which become rapidly activated after disease induction and do not need to infiltrate the pancreas. The pancreas-specific deletion of IKKa, another NFkB inhibitor a phosphorylating kinase, caused spontaneous pancreatitis in mice, 163 but this process appeared to be independent of NFkB. IKKa also regulates autophagic flux, which is essential for pancreas homeostasis. 164 These data demonstrate the complexity of the NFkB network, which often hampers the interpretation of results. Taken together, the constitutive activation of NFkB leads to a chronic infiltration of immune cells, but pancreatitis develops only after induction by an external stimulus. 161, 162 The presence of immune cells within the pancreas is required but insufficient for pancreatitis to develop and these cells need to be activated to contribute to disease severity. Conversely, data from pancreas-specific RelA deleted mice show that NFkB activation in acinar cells is not essential for the recruitment of immune cells to the side of damage. 159 Quite to the contrary, the absence of p65 in acinar cells result in greater disease severity. Although all these studies investigated the role of NFkB in acinar cells, NFkB activation could play a much larger role in infiltrating immune cells, which directly regulate the immune response.
Another master switch in the transcriptional machinery of acinar cells is activator protein 1 (AP1). AP1 is implicated in multiple transcriptional networks within the acinar cells regulating pancreatic development, differentiation, cell death, and inflammation. Mice heterozygous for the orphan nuclear receptor NR5A2 develop an acinar cell-autonomous AP1-dependent pre-inflammatory state, which, on a transcriptome level, mimics that of early AP. 165 However, the extent of NFkB and AP1 activity seems to greatly differ with respect to the cause of pancreatitis. In cerulein models, activation of the 2 transcription factors is described and submaximal CCK stimulation induces acinar cell dedifferentiation and proliferation through the mitogenactivated kinase-c-Jun-AP1 pathway probably as part of a pancreatic regeneration program. 166, 167 In contrast, the metabolites occurring in ethanol-induced experimental pancreatitis can positively and negatively regulate NFkB and AP1 depending on the predominance of oxidative or nonoxidative alcohol metabolism in the pancreas. 168 
Role of Infiltrating Immune Cells
Infiltration of immune cells starts within minutes after the onset of disease and plays a crucial role in the severity and prognosis of pancreatitis. [169] [170] [171] [172] Cells of the innate immune system, such as neutrophil granulocytes and monocytes and macrophages, represent the majority of infiltrating cells. NFkB plays a crucial role in the activation of leukocytes and is a central mediator of the innate and adaptive immune system. 173 Pancreatitis is primarily a sterile inflammation, so pathogen-associated molecular patterns play no role in the activation of immune cells during the early phase of disease. Thus, in pancreatitis, activation of immune cells is mediated by cytokines or DAMPs that arise from acinar cell necrosis. Acinar cells release various cytokines and chemokines in response to CCK stimulation and NFkB activation, such as TNFa, 174 IL6, or monocyte chemoattractant protein 1.
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DAMPs and cytokines result in the nuclear translocation of p65 and p50 within infiltrating immune cells, which enhances the cytokine storm through the secretion of proinflammatory mediators 175 ( Figure 5 ). DAMPs can act in the same way as pathogen-associated molecular patterns through TLRs 176 or specific receptors such as P2RX7, which uses extracellular adenosine triphosphate as a ligand. Acinar cells, which undergo necrotic cell death, release a multitude of different DAMPs, such as free DNA, 177 histones, or free adenosine triphosphate, 138 which can act as immune activators. Activated immune cells increase pancreatic damage and contribute to systemic inflammation. 169, 175, 178 Several studies have focused on different populations of immune cells and their role during AP.
Neutrophil granulocytes are often used as reference markers for pancreatic inflammation by measurements of myeloperoxidase activity in tissue and reflect the amount of infiltrating neutrophils. One major function of neutrophils is removing pathogens by the release of proteases, antimicrobial peptides, and ROS. During pancreatitis, neutrophils are the major source of ROS production; they can induce oxidative damage on acinar cells and enhance trypsinogen activation. 178 The release of proteases such as PMN-elastase contributes to tissue destruction and acinar cell dissociation. 179 These data indicate that neutrophils have a direct effect on disease severity. This was confirmed by the depletion of neutrophils using antineutrophil serum, which resulted in decreased pancreatic damage and protease activation. 169, 178 Recent studies have investigated the role of neutrophil extracellular trap (NET) formation in the context of pancreatitis. NETs are extracellular networks consisting of neutrophil DNA and are used to bind pathogens. 180 This suicide mechanism of neutrophils is a last line of defense against bacterial infections. NET formation is induced by TLR4 activation and the activation of nicotinamide adenine dinucleotide phosphate oxidase, which lead to the oxidation of peptidyl-arginine-deiminase 4. 181, 182 TLR4 is responsible for the detection of pathogens, although DAMPs can activate the TLR-signaling pathway. 176 Merza et al 183 reported that NET formation enhances the immune response during severe AP and is accountable for trypsinogen activation. Treatment with DNAse prevents NET formation and decreases disease severity. 183 In addition to bacterial infections, crystals can induce NET formation. 184 Another group showed that NET formation is a critical step in bile stone development and plays an important role in ductal obstruction contributing to onset and severity of pancreatitis. 185, 186 Neutrophil infiltration during AP is an unspecific reaction of the immune system, which enhances local damage by the formation of NETs and the release of ROS or activates digestive enzymes.
Monocytes and macrophages belong to cells of the innate immune system. In contrast to neutrophil granulocytes, macrophages are characterized by high plasticity. Classic activated macrophages (M1) act in a proinflammatory manner and secrete large amounts of IL6, TNFa, IL12, and IL1b, and increased expression of inducible nitric oxide synthase results in the release of nitric oxide. 187 Alternatively, activated macrophages (M2) are associated with wound healing, tissue regeneration, and fibrogenesis and act in an anti-inflammatory manner through the release of IL10 or transforming growth factor b. They are characterized by decreased inducible nitric oxide synthase and increased arginase 1 expression. 187 Macrophages are phagocytosing cells that remove tissue debris and necrotic and apoptotic cells. During AP, macrophage infiltration correlates to a greater extent with pancreatic damage and necrosis than with the number of Figure 5 . NFkB activation in inflammatory cells. There are multiple pathways of how NFkB could be activated within leukocytes; the major pathways that play a role during AP are depicted. Cytokines such as IL1b or TNFa and DAMP signals acting by TLRs can induce the translocation of p65 and p50 into the nucleus. In leukocytes, most inflammatory mediators are under the control of NFkB: cytokines, chemokines, adhesion molecules, and components of the inflammasome pathway. Leukocytemediated NFkB activation enhances the immune response in a very prominent manner and therefore has a different role in pancreatitis compared with NFkB activation within the acinar cell. ASC, Apoptosis-associated speck-like protein containing a CARD; Casp-1, caspase 1; ICAM-1, intercellular adhesion molecule 1; IL1-R, IL1 receptor; IRAK, interleukin-1 receptorassociated kinase; IkBa, inhibitor of NFkB alpha; MCP-1, monocyte chemoattractant protein 1; MIP-2, macrophage inflammatory protein 2; MMPs, matrix metalloproteinases; NEMO, NF-kappa-B essential modulator; RANTES, regulated on activation, normal T-cell expressed, and secreted; TAK1, transforming growth factor beta-activated kinase 1; TNFR, TNF receptor; TRADD, tumor necrosis factor receptor type 1-associated DEATH domain protein; TRAF2, TNF receptor-associated factor 2; Ub, ubiquitin; VCAM-1, vascular adhesion molecule 1.
infiltrating neutrophils. 175 The reason for that is that macrophages are required for the removal of necrosis and thus mitigate pancreatic damage. Phagocytosing macrophages have been observed in different models of AP and CP. 130, 164, 169, 175 In contrast to apoptosis, necrosis is a proinflammatory cell death because it entails the release of multiple DAMPs that induce an M1 polarization of macrophages. 188 Therefore, acinar cell apoptosis is suggested to be protective against hyperinflammation and decrease disease severity.
189 M1 macrophages release large amounts of TNFa, which have a direct effect on pancreatic acinar cells. 174 Two independent groups reported that TNFa secreted from infiltrating monocytes is responsible for pancreatic damage and digestive protease activation. 169, 190 Depletion of macrophages by clodronatecontaining liposomes decreased disease severity and protected mice from cerulein-induced pancreatitis. 169, 191 TNFa acts on cells by cell death receptors and is necessary to induce cell death by necroptosis through the RIP1-RIP3 pathway, 135 which has been suggested to be the major cell death pathway during AP. 136 Therefore, infiltrating macrophages are responsible for the induction of necroptosis and for the clearance of necrotic areas within the damaged pancreas. 175 In addition to TNFa, macrophages produce large amounts of IL1b, a proinflammatory cytokine associated with the acute disease phase. In contrast to other cytokines, IL1b needs to be processed. During maturation, pro-IL1b and pro-IL18 undergo activation by the caspase 1-inflammasome complex and are released by the gasdermin D-pore complex from the cytosol to the extracellular space. 192 In consequence of this process, the cell undergoes pyroptotic cell death. 192, 193 During pancreatitis, the activation of the inflammasome complex and the release of IL1b contribute critically to disease severity. 138, 139, 175, 177 Inflammasome complex formation and pyroptotic cell death are mainly known from macrophages and are not present in acinar cells. 175 Inflammasome activation is a complex mechanism requiring 2 signals for activation: the first signal induces transcriptional upregulation of inflammasome components by NFkB and the second signal induces oligomerization of the inflammasome complex and the activation of procaspase 1. The major inducer of the inflammasome pathway is the TLR-MyD88 cascade. The second signal, which is necessary for inflammasome complex formation, can be a high potassium influx, TNFa, or the release of cathepsins from phagosomes into the cytosol. 194 Phagocytosis of zymogens by macrophages results in a colocalization of trypsinogen and cathepsin B in nonacinar cell phagolysosomes and results in activation of trypsinogen 175 and macrophage activation. The rupture of these trypsin-and cathepsin B-containing vesicles leads to a cytosolic redistribution of cathepsins that acts as a second signal of inflammasome activation and indirectly links trypsinogen activation to the NFkB pathway through IL1b release. IL1b acts as an activator for other immune cells, with the IL1 receptor being directly linked to the MyD88-NFkB pathway. The importance of IL1b during pancreatitis was nicely shown by a transgenic mouse model of pancreas-specific IL1b-overexpressing mice that developed CP, including complete loss of pancreatic function within weeks after birth. 195 Therefore, M1 macrophages contribute prominently to the systemic immune response syndrome, which is associated with multiorgan dysfunction syndrome and increased mortality. 170 In contrast to M1 macrophages, the M2 phenotype is associated with organ regeneration and fibrosis development. [196] [197] [198] In conclusion, early protease activation and NFkB activation are essential characteristics of pancreatitis; these 2 events occur in parallel during disease manifestation and strongly influence each other. Recent studies have proved that not only the activation of proteases and NFkB but also the type of cell play a critical role, in which where their activation takes place is of importance. Pancreatitis is not a disease of acinar cells alone.
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